News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pernix Therapeutics, Inc. (PTX) Reports Second Quarter 2014 Financial Results


8/11/2014 8:51:15 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MORRISTOWN, N.J.--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (“Pernix” or the “Company”) (NASDAQ: PTX), a specialty pharmaceutical company, today announced financial results for the quarter and year-to-date periods ended June 30, 2014.



Business Update

“The second quarter of 2014 saw tremendous progress toward Pernix’s transformation to profitability of its base business. While we expect fiscal year 2014 sales from our non-promoted products to be relatively flat year over year, we expect our insomnia brand, Silenor, to be a key growth driver,” said Doug Drysdale, Chairman, President and Chief Executive Officer.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES